Yi-Chin Toh is a Professor in the Faculty of Engineering at Queensland University of Technology (QUT), leading the Micro Tissue Engineering Lab. She holds an ARC Future Fellowship and has held prior roles as an Assistant Professor at the National University of Singapore. Her expertise lies in microfluidic tissue models for drug testing and organ-on-a-chip technologies. She earned her B.Eng. (2001) and Ph.D. (2008) in Bioengineering from National University of Singapore, followed by postdoctoral training at MIT and A*STAR. Her research focuses on advancing alternative animal-free technologies, with notable contributions to multi-organ microfluidic platforms and 3D bioprinted tissue models. She has published over 70 peer-reviewed articles, secured eight patents, and received accolades like the 2022 Lab on a Chip Pioneers in Miniaturization Award and 2019 Global 3R Award. She holds editorial roles in journals like Biomicrofluidics and contributes to conferences such as MicroTAS. Key research areas include mechanobiology modeling, hepatic-microbiome interactions, and AI-driven single-cell analysis. Her lab’s work bridges academia and industry, emphasizing translational applications in drug safety and toxicology. Current projects include modular microfluidic platforms for multi-organ interactions and FDA-regulatory compliant non-animal testing systems. Education: B.Eng in Chemical Engineering, National University of Singapore (2001) Ph.D. in Bioengineering, National University of Singapore (2008) Awards & Leadership: Lab on a Chip Lectureship (2022), Global 3R Award (2019), ARC College of Experts member, and leadership roles in MicroTAS conferences. She also leads the ARC Training Centre for Cell and Tissue Engineering Technologies.






